Introduction
Phosphatidic acid (PA) is a transient lipid intermediate that constitutes a minor portion of the total phospholipid pool in resting cells. Upon stimulation of cells with certain agonists, the levels of membrane PA rise rapidly. This observation led to the early speculation that PA may regulate key processes in cellular signalling by functioning as a lipid second messenger. Indeed, a number of studies have implicated PA a variety of cellular functions including the mobilization of intracellular and extracellular Ca2+, activation of the superoxide-generating system in neutrophils and actin polymerization [l] . PA is also known to play a role in growth-factor-induced cell proliferation [2] , and endogenously generated PA has been implicated in proliferative responses to certain receptor-dependent agonists, including epidermal growth factor, platelet-derived growth factor and interleukins 1, 2 and 11. Recently, a PA-dependent activation of mitogen-activated analogue of PA, lyso-PA was without effect in *To whom correspondence should be addressed. this system [3] .
Despite the multiple roles of PA in cellular processes, our understanding of the molecular targets of PA remain inadequate. Therefore we are unable to delineate a mechanistic interpretation of its biological effects. This problem of target assignment extends to other lipid bioeffector molecules as well. A systematic study of lipid-protein interactions is therefore needed to provide important insights into the mechanisms of action of lipid second messengers.
An example in which a molcular target for a membrane lipid has been identified can be found among members of the family of serinelthreonine kinases, collectively known as protein kinase Cs (PKCs). PKCs were initially identified as a group of kinases that were reversibly activated by lipid-soluble membrane components in the presence of Ca2+. Subsequent studies showed that membrane lipids such as diacylglycerol (DAG) and its structural analogue, the tumour promoter PMA, are potent activators of some PKCs, and another membrane lipid, phosphatidylserine (PS), can function as a cofactor for the activation [4] .
Raf-I kinase: similarities to PKC
Raf-1 kinase is another serinelthreonine kinase that shares significant sequence similarities to the PKCs. raf-I was first identified as the transforming gene for the 361 1 murine sarcoma retrovirus [S] . Genetic and biochemical studies identified Raf-1 as a downstream effector of ~21"~'', a small membrane-associated guaninenucleotide-binding protein. Results from biochemical assays and yeast two-hybrid screens demonstrated that Raf-1 binds preferentially to activated (GTP-bound) Ras. This step, leading to translocation of cytosolic Raf-1 to the plasma membrane, appears to be a prerequisite for the activation of Raf-1. Facilitation of Raf-1 translocation by the addition of a membrane-targeting CAAX motif results in activation of Raf-1 independently of Ras. The exact molecular events leading to the activation of Raf-1 at the plasma membrane are not fully understood. It is, however, known that Raf-l activation finally leads to the activation of a kinase cascade, known as the MAPK cascade. A consequence of stimulation of this cascade is the activation of transcription factors such as c-Myc, c-Jun, ~62"'"' and Elk-1 leading to gene transcription [6] .
Analysis of the primary amino acid sequences of Raf-1 and PKCs reveals close similarities. Specifically, both PKC and Raf-1 contain a cysteine-rich domain (CRD) composed of a conserved arrangement of cysteine and histidine residues. Atomic absorption spectroscopic measurements and NMR studies demonstrate that two zinc atoms are co-ordinated to the conserved cysteine and histidine residues via two non-consecutive sets of binding interactions, resulting in two separate metal-binding sites within the CRD of PKC [7, 8] . Identical co-ordination chemistry with zinc also exists within the CRD of Raf-1 kinase [9,10].
Besides co-ordinating zinc, the CRD of PKC is also known to interact with the anionic phospholipid, PS. For a subset of PKCs, known as the classical and neo-PKCs (cPKC and nPKC), the CRD is also the site of interaction with the neutral lipid DAG and phorbol esters [11, 12] . Both DAG and phorbol esters are potent activators of cPKC and nPKC. The CRDs of cPKCs and nPKCs therefore function as molecular targets for the lipids PS and DAG and are therefore critical for PKC activation. Studies employing deletion mutagenesis localized a minimal phorbol-ester-binding fragment to a 43-amino acid sequence (residues 102-144) within the CRD of rat brain PKCy [13] .
The CRD of Raf-I : interaction with PS
The results obtained for the CRD of PKC raise the question whether the CRD of Raf-1 can also function as a lipid-binding domain. When the CRD of Raf-1 was tested for its ability to bind lipids, interaction with PS was observed. The binding to PS displayed an apparent positive co-operativity similar to that observed for PKCs. However, in contrast with the CRD of cPKC and nPKC, the CRD of Raf-1 failed to interact with either DAG or phorbol esters [9] . Therefore, despite similarities in their ability to bind certain lipids (PS), the CRDs of Raf-1 and the PKCs mentioned above clearly exhibit important differences in their lipid-binding specificities. With respect to DAG, the CRD of Raf-1 resembles more closely that of a third category of PKC known as atypical or aPKC. Members belonging to this category include PKC [, A and I . The reason for the CRD of Raf-1 not binding DAG or phorbol ester may be elucidated by comparing the CRD structures in Raf-1 and PKC. The difference in specificities between the two domains can be accounted for by a difference in the structure of one of the loops that is critical for the interaction between PKC and phorbol ester [9] . In addition, the binding of the CRD of PKC to Volume 
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PS does not compete with its ability to bind DAG or phorbol ester, suggesting that the PS-binding site is distinct from the DAG/phorbol esterbinding site [ 141.
Interaction of Raf-I kinase with PA
When the lipid-binding studies were extended from the CRD of Raf-1 to full-length Raf-1, a strong interaction with PA was observed, in addition to that with PS. However, the CRD did not appear to be the site of this strong association with PA. Surprisingly, a C-terminal fragment of Raf-1 (RafC, residues 295-648), lacking the CRD, bound to PA as strongly as full-length Raf-1, indicating the presence of a second lipid-binding site within Raf-1 in addition to the CRD. The binding of RafC to PA generated Hill numbers between 3.3 and 6.2, suggesting positive co-operativity in the interaction. The interaction was furthermore unaffected at high ionic strength, implying that it was not governed solely by ionic forces. On the contrary, it was considerably weakened in the absence of salt.
Of all the lipids tested that are expected to encounter Raf-1 physiologically, only PA exhibited strong interaction. Modification of the charged phosphate headgroup via esterification (to generate phosphatidylmethanol or phosphatidylethanol) abolished binding to RafC. Deletion mutagenesis studies revealed that a 35-amino acid segment (residues 389-423) within the C-terminal domain of human Raf-1 was sufficient for binding PA. Sequence comparison of this segment with other isoforms of Raf-1 (A-Raf, B-Raf) and Raf-1 from different species identified a string of conserved residues that contain both positively charged and hydrophobic domains. A molecular model of this region was generated based on the crystal structure of the CAMP-dependent protein kinase. The model predicted that a charged section within the conserved residues, composed of the tetrapeptide sequence RKTR (residues 399-402), would have high probability of forming an exposed surface of the protein and therefore may form part of the PA-binding site (Figure 1 ). T o test this hypothesis, site-directed mutants were created within the tetrapeptide motif and the resultant mutant proteins tested for their ability to bind PA. Complete deletion of the motif or replacement of the three positively charged amino acids with alanine PMA activates the MAPK pathway via Raf-1 and PKC [15] . It also activates phospholipase D (PLD) via a PKCcc-dependent mechanism in MDCK cells resulting in the generation of PA [16] . In order to determine if the PA generated by PMA-activated PLD has a role in the regulation of Raf-1, the production of PA derived from PLD was selectively blocked with ethanol and the effect of such treatment on Raf-1 translocation was monitored. In the presence of ethanol, PLD catalyses a transphosphatidylation reaction generating phosphatidylethanol at the expense of PA. In vitm binding studies had previously
shown that phosphatidylethanol was incapable of binding Raf-1. MDCK cells were stimulated with 10 nM PMA in the presence of various concentrations of ethanol for 15 min. In the absence of ethanol, PMA caused a marked and rapid translocation of both Raf-1 and PKCcc to the cell membrane. In the presence of ethanol, however, the translocation of Raf-1 was significantly inhibited in direct proportion to the concentration of ethanol, whereas the translocation of PKCa was unaffected [17] . These results suggest a role for PLD-derived PA in the specific regulation of Raf-1 translocation in vivo. Since membrane association is a critical step in the activation of Raf-1, the loss of membrane translocation is expected to result in an ultimate attenuation of Raf-1 activation. Thus PA, which is a potent mitogen, may exert its bioactivity by regulating the activation of Raf-1 kinase. Since the activation of Raf-1 would, in turn, lead to the activation of the MAPK cascade, one might expect PA to be responsible for the activation of this pathway. The MAPK pathway has been associated with proliferative responses and therefore may provide one explanation for the mitogenic properties of PA. Recent experiments have been designed to investigate the effect of PA on the MAPK cascade. The results from mouse 3T3-Ll cells show that the generation of PLDderived PA via interleukin 11 treatment of cells or the exogenous addition of PA indeed does lead to activation of MAPK [3] .
Conclusion
It is possible that, besides regulating the translocation of Raf-1 by facilitating membrane retention of Raf-1, PA and PS may also behave as direct modulators of Raf-1 kinase activity. Although no unequivocal data exist at present to support or negate this assumption, an isoform of Raf, B-Raf, has been shown to be activated by PS in a Ras-dependent manner [18] . However, since B-Raf displays significantly different biochemical properties and also appears to be differently regulated from Raf-1, the results obtained with this isoform of Raf cannot be extrapolated to Raf-1. Whether Raf-1-interacting lipids such as PS and PA indeed regulate its kinase activity therefore requires experimental investigation with purified enzymes in well-defined in vitro systems.
The interaction of Raf-1 with PS and PA at distinct regions within the protein exemplifies the variety and subtlety of lipid-protein interactions. In addition, since Raf-1 appears to be a molecular target for the second messenger PA, the mitogenicity of this lipid may be mediated through Raf-1 and the downstream MAPK pathways. An understanding of the roles of PS and PA in the regulation of Raf-1 activity should provide important insights into how membrane lipids act as modulators of critical components of signal-transduction pathways. and diacylglycerol (DAG). Ins( 1 ,4,5)P3 induces mobilization of Ca2+ from intracellular stores [3] . DAG activates protein kinase C (PKC), originally described as a Ca*+-activated phospholipid-dependent protein kinase [S] . The early findings, that the potent tumour promoters of the phorbol ester family can substitute for DAG in PKC activation and that the phorbol ester receptor and PKC co-purify, supported the hypothesis that the cellular target of the phorbol esters is PKC [6] . A large number of cellular studies demonstrated that phorbol esters, preAbbreviations used: PLC, phospholipase C; DAG, diacylglycerol; PKC, protein kinase C; PKD, protein kinase D; CaM kinase, Ca'+/calmodulin-dependent protein kinase; PDB, phorbol 12,13-dibutyrate; PS, phosphatidylserine; MAPK, mitogen-activated protein kinase. *To whom correspondence should be addressed. sumably acting through PKC, induce a wide range of biological effects, including changes in ion flux, gene expression, cell-cell communication, cell differentiation and proliferation Subsequent studies revealed the diversity of the individual components of the DAG-PKC signal-transduction pathway. It has become apparent that PLC exists in several molecular forms which are regulated by G-proteins and tyrosine phosphorylation [ 111. Furthermore DAG can be generated by several alternative routes, including the hydrolysis of phosphatidylcholine [ 121. Molecular cloning has demonstrated the presence of multiple related PKC isoforms, which are differentially expressed in cells and tissues [2, 13, 14] . All members of the PKC family, i.e. conventional or classical PKCs (tl, PI, PII, y), novel PKCs (6, E , q , 0) and atypical PKCs (i, 1, i ) , possess a highly conserved catalytic domain. Most of the variation between the PKC subspecies occurs in the regulatory domain. T h e C1 region of this domain of both conventional and novel PKCs has a tandem repeat of zinc-finger-like cysteine-rich motifs that confers phospholipid-dependent phorbol ester and DAG binding on these PKC isoforms [15-201. In contrast, atypical PKCs contain a single cysteine-rich motif and they neither bind phorbol esters nor are regulated by DAG [15, 21, 22 
